Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

Before you go, we thought you'd like these...
Before you go close icon

Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NAS: IRWD) will present a corporate update at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2013 at 4:05 p.m. Eastern Time at the Grand Hyatt New York.

A live webcast of Ironwood's presentation will be accessible through the Investors section of the company's website at To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood's website for 14 days following the conference.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NAS: IRWD) is committed to the art and science of making medicines, from discovery through commercialization. We're focused on three goals: transforming knowledge into medicines that make a difference for patients, creating value that will inspire the continued support of our fellow shareholders, and building a team that passionately pursues excellence. Our first product, linaclotide, is approved in the United States and Europe. Our pipeline priorities include exploring further opportunities for linaclotide, leveraging our deep expertise in functional gastrointestinal disorders, and advancing programs in other areas such as allergic conditions, cardiovascular disease, central nervous system disorders and other conditions defined by patient symptoms. Ironwood was founded in 1998 and is headquartered in Cambridge, Mass. Connect with us at or on Twitter at to learn more about Ironwood. Information that may be important to investors will be routinely posted in both these locations.

Ironwood Pharmaceuticals, Inc.
Media Relations
Lisa Buffington, 617-374-5103
Vice President, Corporate Communications
Investor Relations
Meredith Kaya, 617-374-5082
Director, Investor Relations

KEYWORDS:   United States  North America  Massachusetts  New York


The article Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

People are Reading